Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment.
about
A practical algorithm for managing Alzheimer's disease: what, when, and why?Clinical Recommendations for the Use of Donepezil 23 mg in Moderate-to-Severe Alzheimer's Disease in the Asia-Pacific RegionHealth Care Service Utilization of Dementia Patients before and after Institutionalization: A Claims Data Analysis.Increased health service utilization costs in the year prior to institutionalization: findings from the canadian study of health and aging.Early-versus Late-Onset Alzheimer Disease: Long-Term Functional Outcomes, Nursing Home Placement, and Risk Factors for Rate of ProgressionResponse to cholinesterase inhibitors affects lifespan in Alzheimer's disease.Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer's disease cohortSolitary living in Alzheimer's disease over 3 years: association between cognitive and functional impairment and community-based services.Responder analysis of a randomized comparison of the 13.3 mg/24 h and 9.5 mg/24 h rivastigmine patch.Predictors of long-term cognitive outcome in Alzheimer's diseaseTransitions in care for older adults with and without dementia.Gender Differences in Institutional Long-Term Care Transitions.Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer's disease: a prospective, observational study of factors affecting survival time from admission to death.Efficacy of 13.3 mg/24 h versus 4.6 mg/24 h rivastigmine patch on activities of daily living in severe Alzheimer's disease.Real-world evaluation of compliance and preference in Alzheimer's disease treatment.Management of patients with Alzheimer's disease: pharmacological treatment and quality of lifeA longitudinal study of risk factors for community-based home help services in Alzheimer's disease: the influence of cholinesterase inhibitor therapy.Biomarkers of basic activities of daily living in Alzheimer's disease.A three-year follow-up on the efficacy of psychosocial interventions for patients with mild dementia and their caregivers: the multicentre, rater-blinded, randomised Danish Alzheimer Intervention Study (DAISY).Vascular biomarkers to predict response to exercise in Alzheimer's disease: the study protocol.Use of health and social care services in a cohort of Italian dementia patients.Progression of mild Alzheimer's disease: knowledge and prediction models required for future treatment strategies.Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer's diseaseA review of the methods used to estimate the cost of Alzheimer's disease in the United States.Systematic review of non-pharmacologic interventions to delay functional decline in community-dwelling patients with dementia.The effectiveness of adult day services for older adults: a review of the literature from 2000 to 2011.Discharge Home From Hospital: How DIRE Can It Be?Predictors of long-term care placement in persons with dementia: a systematic review and meta-analysis.Factors related to continuous and discontinuous attendance at memory clinics.Deciding to institutionalize: caregiving crisis, intergenerational communication, and uncertainty management for elders and their children in Shanghai.Changes of Health Status and Institutionalization Among Older Adults in China.Living Alone with Alzheimer's Disease and the Risk of Adverse Outcomes: Results from the Plan de Soin et d'Aide dans la maladie d'Alzheimer Study.Group and individual cognitive therapies in Alzheimer's disease: the ETNA3 randomized trial.Health economic analysis on a psychosocial intervention for family caregivers of persons with dementia.Efficacy of higher dose 13.3 mg/24 h rivastigmine patch on instrumental activities of daily living in patients with mild-to-moderate Alzheimer's disease.People with dementia in long-term care facilities: an exploratory study of their activities and participation.The Effect of Adult Day Services on Delay to Institutional Placement.Dementia, Disclosing the Diagnosis.Adverse Events in Home Care: Identifying and Responding with interRAI Scales and Clinical Assessment Protocols.Men Lacking a Caregiver Have Greater Risk of Long-Term Nursing Home Placement After Stroke.
P2860
Q26859831-3873FC66-04B4-4B0C-94A1-6FA7566A5BF7Q28067006-076D79E2-ADAD-44B4-ACB8-F02BDC10BBACQ30863627-2F9C7EDB-61F2-44B1-877F-50A9FDB31C40Q33685782-786236B8-BD3D-443C-A68C-DCB33AB65077Q33801636-A3147DEB-D87E-4559-AA0E-E88B13153B87Q34233759-83472EEB-E201-4A98-ABD3-EBFB99BD3EC6Q34466802-FAD5DCF4-552F-4E39-8DD1-21EE7CD1DEB3Q34548336-3804AED7-1263-4028-851A-A09B2677FEC5Q35158572-DD7614A6-B732-4C5E-81FE-9CBA87D35C7EQ35579243-FC0B9EAC-23A1-4D13-8ED3-D115ADE8DAB1Q35967441-6138D2B2-6C27-44FC-ABDF-1CB25E683248Q36058935-2E3E22E6-626F-4473-B7C1-17E8A2B3C296Q36118948-B7651C1B-2B39-4B00-8FA7-B7F101C15E70Q36165980-FF97508C-2621-4535-B4BF-58E12DD8D719Q36264977-3DBF3699-8E17-4004-AF4B-93B3DBA7482BQ36515587-B6DCAE4E-7224-4A30-83F1-DCFA3A4D7F11Q36723409-432C7895-8E49-4047-9EEC-B1A66E8FA912Q36818214-0D16FA02-75D7-4C2E-B018-9891FDD1D60BQ37342379-1421467C-9F7D-4DC0-9BE3-1E0514C56EC0Q37576656-D0D7D37B-5210-4D9A-BC2C-73353C003301Q37632894-59D53A1E-6A13-488F-A1B8-750106CC5728Q37690649-25EC0DA4-FF5D-41E4-993D-23CF249D0AC9Q37708297-0931C7AD-8592-41F7-9B8A-B5AEA507C2C8Q37874387-17BA5111-A14B-443D-846D-8777354B9F0EQ38101072-FC59F10B-DB54-49F5-BB4F-EE15FB713AA7Q38197992-ED76EF75-F1C0-4076-8699-5964D7DF39C0Q38635319-B2490DC7-749C-4770-AD60-07475134B52BQ38798301-0089BE89-4CCA-4E71-9591-56253A9CF535Q38934118-DF9643DB-33DB-45F7-9EF9-F11C05D90623Q40205836-FD83AC72-A1D0-47CC-B317-691968E46AE1Q41026604-1535CC15-CC9B-41EF-BEA0-6E28DD9EC839Q41031505-C8FC262F-A77D-48A1-A9F6-A968068F1B89Q41120871-681CBFA8-4A08-470F-B8CC-2B517840A649Q44012664-D585DC02-AD91-4C7E-B7DB-9DEB842CF0E1Q44542466-BD4A8037-DAAF-4FA8-81B2-B5DAEAB4D353Q46001072-4A80A46B-4D73-4425-9EC3-61966A8AEB6BQ46305050-29D7E3F7-F0F8-459A-83C2-1070D6268584Q47549454-D7B3C87F-C6BB-4914-8300-42F7CCCEB297Q47558398-D2FCD2BD-D8F9-4108-9346-9D9B56739E1EQ47630333-8EEC1510-0392-4825-876B-B121C42E1ECF
P2860
Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Risk factors for nursing home ...... nesterase inhibitor treatment.
@en
Risk factors for nursing home ...... nesterase inhibitor treatment.
@nl
type
label
Risk factors for nursing home ...... nesterase inhibitor treatment.
@en
Risk factors for nursing home ...... nesterase inhibitor treatment.
@nl
prefLabel
Risk factors for nursing home ...... nesterase inhibitor treatment.
@en
Risk factors for nursing home ...... nesterase inhibitor treatment.
@nl
P2860
P356
P1433
P1476
Risk factors for nursing home ...... nesterase inhibitor treatment.
@en
P2093
Asa K Wallin
Carina Wattmo
P2860
P356
10.1093/GERONT/GNQ050
P577
2010-06-20T00:00:00Z